Martine Piccart

Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors.

M. Piccart, J. Verweij, A. Sparreboom, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers

M. Piccart, A. Awada, T. Gil, 2004, Anti-cancer drugs.

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

M. Piccart, M. Nooij, L. Beex, 2002, European journal of cancer.

The pipeline of new anticancer agents for breast cancer treatment in 2003.

M. Piccart, F. Cardoso, A. Awada, 2003, Critical reviews in oncology/hematology.

Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?

M. Piccart, F. Cardoso, C. Lohrisch, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.

M. Piccart, M. Nooij, R. Paridaens, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

EORTC 10941: A phase II study of liarozole in postmenopausal patients with ‘Chemotherapy-Resistant’ or ‘Potentially Hormone Sensitive’ metastatic breast cancer

J. Klijn, M. Piccart, R. Paridaens, 2000, Breast Cancer Research and Treatment.

Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors.

M. Piccart, J. Verweij, A. Sparreboom, 2001, Journal of Clinical Oncology.

Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002

C. Sotiriou, D. Larsimont, M. Piccart, 2002, International Journal of Clinical Oncology.